McKesson Appoints Tom Rodgers to Executive Vice President & Chief Strategy and Business Development Officer
June 04 2020 - 4:15PM
Business Wire
Dave Schulte has been named Rodger’s successor
to lead McKesson Ventures
McKesson Corporation (NYSE:MCK) today announced Tom Rodgers has
been appointed executive vice president and chief strategy and
business development officer effective June 5, 2020. In his new
role, Rodgers will also become a member of the company’s Executive
Operating Team. Rodgers succeeds Bansi Nagji who stepped down from
his role effective March 31, 2020.
“McKesson has a long history of evolving our company in
meaningful ways that enable us to lead in a rapidly changing
healthcare environment,” said Brian Tyler, CEO, McKesson
Corporation. “Tom’s experience in both venture capital and large
healthcare environments, will be extremely valuable to our
leadership team as we continue to strengthen our core business and
transform our company to create new opportunities to deliver future
growth.”
As executive vice president and chief strategy and business
development officer, Rodgers will have responsibility for the
company’s overall strategic plan and initiatives, as well as key
acquisitions and internal programs that drive financial
performance, enhance innovation and deliver added value for our
customers.
Rodgers currently serves as senior vice president and managing
director for McKesson Ventures. Rodgers has more than twenty-five
years of experience working in emerging companies, large healthcare
environments as well as venture capital firms. Prior to McKesson
Ventures, Tom served as Director, Strategic Investments, Cambia
Health and was a partner at Advanced Technology Ventures, where he
led the fund’s investments in healthcare technology. Tom previously
worked for McKesson from 2001 to 2004 as Vice President, Corporate
Strategy and Business Development. He holds an M.B.A. from the
Wharton School and a B.A. from the University of Pennsylvania.
Additionally, Dave Schulte has been named Rodger’s successor to
lead McKesson Ventures, McKesson’s strategic venture capital firm
that focuses on investing in innovative approaches to address
business challenges facing the healthcare industry.
Dave joined McKesson in 2015 and has most recently served as
managing director for McKesson Ventures. Dave has more than 20
years of experience as an investor and investment banker,
partnering with entrepreneurs to build innovative healthcare and
technology businesses. Prior to joining McKesson, Schulte ran
Kaiser Permanente Ventures where he helped to build the investment
program from $20M to $400M of assets under management. Dave is a
graduate of St. John's University and earned a Master of Public
Policy degree from Harvard University.
About McKesson Corporation
McKesson Corporation is a global leader in healthcare supply
chain management solutions, retail pharmacy, community oncology and
specialty care, and healthcare information technology. McKesson
partners with pharmaceutical manufacturers, providers, pharmacies,
governments and other organizations in healthcare to help provide
the right medicines, medical products and healthcare services to
the right patients at the right time, safely and cost-effectively.
United by our ICARE shared principles, our employees work every day
to innovate and deliver opportunities that make our customers and
partners more successful — all for the better health of patients.
McKesson has been named the “Most Admired Company” in the
healthcare wholesaler category by FORTUNE, a “Best Place to Work”
by the Human Rights Campaign Foundation, and a top
military-friendly company by Military Friendly. For more
information, visit www.mckesson.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200604005679/en/
Holly Weiss, 972-969-9174 (Investors)
Holly.Weiss@McKesson.com
David Matthews, 214-952-0833 (Media)
David.Matthews@McKesson.com
McKesson (NYSE:MCK)
Historical Stock Chart
From Aug 2024 to Sep 2024
McKesson (NYSE:MCK)
Historical Stock Chart
From Sep 2023 to Sep 2024